Minecraft Live has just wrapped up, and Mojang's latest showcase from Twitchcon Rotterdam has delivered plenty of juicy new details about what's coming to the sandbox game in the next few months. The ...
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company advancing a new class of molecular glue degraders to target historically undruggable proteins, today announced the ...
Financing will support the ongoing Phase 1/2 trial of NEO-811 for the treatment of locally advanced or metastatic non-resectable clear cell renal cell carcinoma (ccRCC) and the continued advancement ...
Its new cancer drug makes cells self-destruct. Investors bet another $100M on this San Diego startup
San Diego startup Neomorph on Monday announced a new $100 million investment for its molecular glue that tricks cancer cells into self-destructing. Even as it awaits results from its first clinical ...
Initiation of trial marks first-in-human milestone for Neomorph's novel molecular glue degrader platform SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering ...
This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it's putting that claim to the test. After attracting global attention from ...
A molecular glue designed to make cancer cells self-destruct has now entered human testing for kidney cancer. (). A San Diego biotechnology company claims its molecular glue can prompt cancer cells to ...
SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) — Neomorph, Inc., a biotechnology company pioneering molecular glue degraders to address previously undruggable proteins, today announced the first patient ...
The Minecraft Bedrock 1.21.131 update is now available, introducing fixes and changes to the content introduced in the latest Mounts of Mayhem drop. This hotfix addresses certain performance and ...
AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and immunology, with the deal worth $1.64bn. The collaboration and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results